1. Home
  2. CBU vs MRUS Comparison

CBU vs MRUS Comparison

Compare CBU & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBU
  • MRUS
  • Stock Information
  • Founded
  • CBU 1866
  • MRUS 2003
  • Country
  • CBU United States
  • MRUS Netherlands
  • Employees
  • CBU N/A
  • MRUS N/A
  • Industry
  • CBU Major Banks
  • MRUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CBU Finance
  • MRUS Health Care
  • Exchange
  • CBU Nasdaq
  • MRUS Nasdaq
  • Market Cap
  • CBU 2.8B
  • MRUS 2.7B
  • IPO Year
  • CBU N/A
  • MRUS 2016
  • Fundamental
  • Price
  • CBU $56.29
  • MRUS $56.07
  • Analyst Decision
  • CBU Buy
  • MRUS Strong Buy
  • Analyst Count
  • CBU 3
  • MRUS 15
  • Target Price
  • CBU $71.00
  • MRUS $88.87
  • AVG Volume (30 Days)
  • CBU 174.4K
  • MRUS 1.6M
  • Earning Date
  • CBU 07-22-2025
  • MRUS 05-07-2025
  • Dividend Yield
  • CBU 3.27%
  • MRUS N/A
  • EPS Growth
  • CBU 16.34
  • MRUS N/A
  • EPS
  • CBU 3.61
  • MRUS N/A
  • Revenue
  • CBU $741,961,000.00
  • MRUS $54,732,000.00
  • Revenue This Year
  • CBU $14.01
  • MRUS $39.00
  • Revenue Next Year
  • CBU $8.95
  • MRUS $7.48
  • P/E Ratio
  • CBU $15.57
  • MRUS N/A
  • Revenue Growth
  • CBU 7.37
  • MRUS 42.77
  • 52 Week Low
  • CBU $42.16
  • MRUS $33.19
  • 52 Week High
  • CBU $73.39
  • MRUS $61.28
  • Technical
  • Relative Strength Index (RSI)
  • CBU 49.24
  • MRUS 66.86
  • Support Level
  • CBU $55.87
  • MRUS $49.46
  • Resistance Level
  • CBU $57.01
  • MRUS $56.74
  • Average True Range (ATR)
  • CBU 1.09
  • MRUS 3.37
  • MACD
  • CBU -0.14
  • MRUS 1.57
  • Stochastic Oscillator
  • CBU 30.54
  • MRUS 91.31

About CBU Community Bank System Inc.

Community Financial System Inc is a diversified financial services company providing a broad array of banking and other financial services to retail, commercial, institutional and governmental customers. The Company also offers comprehensive financial planning, trust administration and wealth management services through its Community Bank Wealth Management operating unit. It has four reportable operating business segments: Banking and Corporate, Employee Benefit Services, Insurance Services and Wealth Management Services.

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Share on Social Networks: